RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: all available years, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Your saved research and appointment questionsView recorded trial and retraction changes
Blepharophimosis-Intellectual Disability Syndrome, Ohdo Type: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
A RARE GENETIC DISORDER CAUSED BY A KAT6B MUTATION: PHENOTYPIC MANIFESTATIONS BASED ON A CLINICAL CASE
Н. І. Токарчук et al., Neonatology surgery and perinatal medicine (29 December 2025)
https://doi.org/10.24061/2413-4260.xv.4.58.2025.32
- 2.
Ohdo syndrome in a Filipino teen
Terence Aaron Lim Burgo et al., Case Reports in Clinical Radiology (29 September 2025)
https://doi.org/10.25259/crcr_90_2025
- 3.
Ohdo Syndrome in a Filipino Teen
Terence Aaron Lim Burgo et al., Preprints.org (25 July 2025)
https://doi.org/10.20944/preprints202507.2198.v1
- 4.
Skeletal Survey of a Filipino Teenage Female with Ohdo syndrome: Case Report
Terence Aaron Lim Burgo et al. (24 July 2025)
https://doi.org/10.1590/scielopreprints.12720
- 5.
Loss of KAT6B causes premature ossification and promotes osteoblast differentiation during development.
Bergamasco Maria I et al., Developmental biology (1 April 2025)
https://pubmed.ncbi.nlm.nih.gov/39832706/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Blepharophimosis-Intellectual Disability Syndrome, Ohdo Type
Ohdo syndrome is a very rare developmental condition marked by narrowed eye openings with drooping eyelids, distinctive facial features and intellectual disability. Hearing loss, dental problems, heart defects and low muscle tone may also occur. There is no specific treatment, so care is supportive and involves eyelid surgery where needed, early developmental support, and regular review of hearing, vision and heart health.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Blepharophimosis-Intellectual Disability Syndrome, Ohdo Type is very rare and little research has been published, so this page includes research from every year, including case reports about individual patients. Case reports are marked, and describe one person's experience rather than tested results.
Most Recent Research
Disorders associated with pathogenic variants in the lysine acetyltransferase 6B (KAT6B) gene, located at chromosome 10q22.2, constitute a clinically heterogeneous group, historically divided into two allelic syndromes: Say–Barber–Biesecker–Young–Simpson syndrome (SBBYSS), regarded as a variant of Ohdo syndrome, and genitopatellar syndrome (GPS). Both conditions typically arise from heterozygous pathogenic variants in the terminal exons of KAT6B. As the number of reported cases with overlapping SBBYSS/GPS phenotypes has increased, these entities are now collectively classified as KAT6B-related disorders or the KAT6B spectrum. Individuals with SBBYSS commonly present with characteristic facial dysmorphic features, generalised hypotonia, joint hypermobility, feeding difficulties, and long thumbs and great toes. Skeletal anomalies, particularly patellar hypoplasia, are frequently observed. Genitopatellar syndrome (GPS) is distinguished by severe developmental delay and genital anomalies. This report describes an 11-month-old male diagnosed with a KAT6B-related disorder following identification of a heterozygous pathogenic missense variant in the KAT6B gene, confirmed by molecular genetic testing. The phenotype included craniofacial dysmorphism, developmental delay and speech impairment, hypotonia, blepharophimosis, long thumbs, skeletal anomalies, a congenital renal anomaly, and seizures. The clinical presentation exhibited a blend of features characteristic of both SBBYSS and GPS. Publication of this case was authorised by written informed consent from the patient’s mother and conducted in accordance with bioethical principles. Conclusion. The constellation of anomalies observed in this patient fulfils clinical criteria for both SBBYSS and GPS, reinforcing the concept of a continuous phenotypic spectrum within KAT6B-related disorders. Further genotype–phenotype correlation studies are warranted to delineate the full clinical variability and refine diagnostic criteria across this spectrum.
Common Questions
What is Blepharophimosis-Intellectual Disability Syndrome, Ohdo Type?
Ohdo syndrome is a very rare developmental condition marked by narrowed eye openings with drooping eyelids, distinctive facial features and intellectual disability. Hearing loss, dental problems, heart defects and low muscle tone may also occur. There is no specific treatment, so care is supportive and involves eyelid surgery where needed, early developmental support, and regular review of hearing, vision and heart health.
How many clinical trials are available for Blepharophimosis-Intellectual Disability Syndrome, Ohdo Type?
No clinical trials are currently indexed for Blepharophimosis-Intellectual Disability Syndrome, Ohdo Type. This may change as new trials are registered. Check back regularly or visit ClinicalTrials.gov directly.
Where does the research data for Blepharophimosis-Intellectual Disability Syndrome, Ohdo Type come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Blepharophimosis-Intellectual Disability Syndrome, Ohdo Type.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.